ACSLX
Price
$105.15
Change
-$0.04 (-0.04%)
Updated
Dec 3 closing price
Net Assets
6.53B
RGACX
Price
$86.23
Change
+$0.52 (+0.61%)
Updated
Dec 3 closing price
Net Assets
338.91B
Interact to see
Advertisement

ACSLX vs RGACX

Header iconACSLX vs RGACX Comparison
Open Charts ACSLX vs RGACXBanner chart's image
American Century Select C
Price$105.15
Change-$0.04 (-0.04%)
VolumeN/A
Net Assets6.53B
American Funds Growth Fund of Amer R3
Price$86.23
Change+$0.52 (+0.61%)
VolumeN/A
Net Assets338.91B
ACSLX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
ACSLX vs. RGACX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACSLX is a Buy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 339B vs. ACSLX (6.53B). RGACX pays higher dividends than ACSLX: RGACX (0.07) vs ACSLX (0.00). ACSLX was incepted earlier than RGACX: ACSLX (23 years) vs RGACX (24 years). ACSLX (1.98) is less costly to investors than RGACX (0.94). RGACX is a more actively managed with annual turnover of: 25.00 vs. ACSLX (18.00). RGACX has a lower initial minimum investment than ACSLX: RGACX (250) vs ACSLX (2500). ACSLX annual gain was more profitable for investors over the last year : 8.91 vs. RGACX (6.46). RGACX return over 5 years is better than : 29.83 vs. ACSLX (19.86).
ACSLXRGACXACSLX / RGACX
Total Expense Ratio1.900.94202%
Annual Report Gross Expense Ratio1.980.94211%
Fund Existence23 years24 years-
Gain YTD15.12518.55881%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.53B339B2%
Annual Yield % from dividends0.000.07-
Returns for 1 year8.916.46138%
Returns for 3 years44.2060.0974%
Returns for 5 years19.8629.8367%
Returns for 10 years84.2989.9094%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEPH5.430.20
+3.80%
Nephros
WTFCN26.34-0.03
-0.11%
Wintrust Financial Corp
HSIC71.65-1.46
-2.00%
Henry Schein
PTLO4.94-0.14
-2.76%
Portillo's
NRIX16.35-0.56
-3.31%
Nurix Therapeutics